AZD4512 monotherapy clinical trials

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

This study is testing a new medicine, AZD4512, for B-cell Acute Lymphoblastic Leukaemia (B-ALL) in people whose cancer has come back or not responded to other treatments. Researchers want to see if it's safe and how well it works.